Ascendis Pharma A/S (NASDAQ:ASND) Price Target Raised to $280.00
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) had its price objective raised by Evercore ISI from $260.00 to $280.00 in a report released on Friday,Benzinga reports. Evercore ISI currently has an outperform rating on the biotechnology company’s stock. ASND has been the subject of several other reports. Royal Bank of Canada assumed coverage on shares […]
Ascendis Pharma A/S (NASDAQ:ASND – Free Report) had its price objective raised by Evercore ISI from $260.00 to $280.00 in a report released on Friday,Benzinga reports. Evercore ISI currently has an outperform rating on the biotechnology company’s stock. ASND has been the subject of several other reports. Royal Bank of Canada assumed coverage on shares […]
